Finance News – Pharmaceuticals
What is your interest today?
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
PBS 'not on the table' to escape concerning pharmaceuticals tariff
The government remains committed to maintaining the current drug subsidy program despite potential economic challenges posed by a significant tariff increase on pharmaceutical expo...
Read Full Article →Live: Australia 'urgently' seeking further detail on Trump's pharmaceutical tariffs
Australia is actively requesting more information from the United States regarding the potential imposition of high tariffs on pharmaceutical imports, which could substantially imp...
Read Full Article →US will hike tariffs on copper to 50%, Trump says
Increasing tariffs on copper and potentially other key industries such as pharmaceuticals, lumber, and semiconductors could significantly impact trade costs and market prices acros...
Read Full Article →Trump flags tariffs of 200pc on pharmaceuticals, 50pc on copper
A proposed increase in tariffs on pharmaceuticals and copper could substantially impact Australia's export revenues by significantly raising costs for these key commodities in the...
Read Full Article →Trump threatens to impose up to 200% tariff on pharmaceuticals 'very soon'
The potential introduction of substantial tariffs on pharmaceutical products could considerably affect pricing structures and market dynamics, with implementation possibly delayed...
Read Full Article →The weight loss drug boom has barely begun. How big can it get?
The rising popularity of GLP-1 medications, including Ozempic, positions them to generate substantial revenue, potentially surpassing established blockbuster drugs like statins in...
Read Full Article →UK business set to gain big from India trade deal, says minister
The recently established trade agreement between the UK and India is expected to enhance economic opportunities for companies in sectors like finance, healthcare, and education by...
Read Full Article →Pfizer and other drug companies make 'no commitments' to the White House on lower drug prices
Pfizer’s reluctance to guarantee reduced medication costs highlights ongoing challenges in achieving significant price cuts despite recent government efforts aimed at lowering expe...
Read Full Article →Bayer shares soar as company records strong cancer drug demand
Bayer’s pharmaceutical segment significantly boosted its revenue in the first quarter, contributing to a notable increase in share value despite underperformance in the agricultura...
Read Full Article →Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
Fennec Pharmaceuticals demonstrated increased income during the initial quarter of 2025, driven by strategic sales efforts and improved assistance for patients, reflecting overall...
Read Full Article →Trump signs order to boost domestic drug manufacturing as pharma tariffs loom
The directive aims to enhance domestic production of medications, potentially reducing reliance on imports and impacting the cost structure of pharmaceuticals in the U.S. market.
Read Full Article →Americans would suffer most if Trump imposes pharma tariffs, sector warns
Imposing tariffs on pharmaceutical imports could disrupt supply chains and increase medication costs, potentially making essential treatments less accessible for many individuals a...
Read Full Article →